Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hermann

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
BMC Infectious Diseases|April 3, 2022
Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohortsAksana Jones, Jay Saini, Belinda Kriel, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2026
A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse modelSylvie Sordello, Laure Brock, Alessia Tagliavini, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2005
How modeling and simulation have enhanced decision making in new drug developmentRaymond Miller, Wayne Ewy, Brian W Corrigan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 2, 2024
Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeuticsCindy X Zhang, Thomas M Conrad, David Hermann, et al.
The Lancet. Digital Health|May 24, 2024
Prediction of diagnosis and diastolic filling pressure by AI-enhanced cardiac MRI: a modelling study of hospital dataDavid Hermann Lehmann, Bruna Gomes, Niklas Vetter, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
BMC Infectious Diseases|April 3, 2022
Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohortsAksana Jones, Jay Saini, Belinda Kriel, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2026
A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse modelSylvie Sordello, Laure Brock, Alessia Tagliavini, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2005
How modeling and simulation have enhanced decision making in new drug developmentRaymond Miller, Wayne Ewy, Brian W Corrigan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 2, 2024
Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeuticsCindy X Zhang, Thomas M Conrad, David Hermann, et al.
The Lancet. Digital Health|May 24, 2024
Prediction of diagnosis and diastolic filling pressure by AI-enhanced cardiac MRI: a modelling study of hospital dataDavid Hermann Lehmann, Bruna Gomes, Niklas Vetter, et al.
Pageof 4